Product
AXA1125
1 clinical trial
1 indication
Clinical trial
A Randomized, Double-Blind, Placebo-Controlled Pilot Study to Evaluate the Efficacy, Safety, and Tolerability of AXA1125 in Subjects With Fatigue-Predominant Post-Acute Sequelae of SARS-CoV-2 (PASC) InfectionStatus: Completed, Estimated PCD: 2022-06-21